Longboard Pharmaceuticals, Inc. | Business Contracts

Underwriting Agreement by and among the Company, Evercore Group L.L.C. and Cantor Fitzgerald & Co. dated February 7, 2023 (Filed With SEC on February 8, 2023)

Second Amendment to License Agreement by and between the Registrant and Arena Pharmaceuticals, Inc., dated September 13, 2022 (Filed With SEC on November 3, 2022)

Amended and Restated Offer Letter by and between the registrant and Brandi L. Roberts, dated March 1, 2021 (Filed With SEC on March 8, 2021)

Amended and Restated Employment Agreement by and between the registrant and Kevin R. Lind, dated March 1, 2021 (Filed With SEC on March 8, 2021)

Services Agreement by and between the registrant and Arena Pharmaceuticals, Inc., dated October 27, 2020 (Filed With SEC on February 19, 2021)

January 2022 amendment to Arena License Agreement (Filed With SEC on March 3, 2022)

Description of Capital Stock (Filed With SEC on March 3, 2022)

Longboard Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on March 8, 2021)

Exchange Agreement by and among the registrant and the stockholders listed therein, dated March 5, 2021 (Filed With SEC on March 8, 2021)

Amended and Restated Offer Letter by and between the registrant and Philip Perera, M.D., dated March 1, 2021 (Filed With SEC on March 8, 2021)

Non-Employee Director Compensation Policy (Filed With SEC on March 8, 2021)

Longboard Pharmaceuticals, Inc. Performance Bonus Plan (Filed With SEC on March 8, 2021)

Forms of grant notice, stock option agreement and notice of exercise under the Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 8, 2021)

Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 8, 2021)

Forms of restricted stock award grant notice and restricted stock award terms and conditions under the Longboard Pharmaceuticals, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 8, 2021)

Form of Common Stock Certificate (Filed With SEC on March 8, 2021)

Form of Underwriting Agreement (Filed With SEC on March 8, 2021)

Longboard Pharmaceuticals, Inc. 2020 Equity Incentive Plan (Filed With SEC on February 19, 2021)

Royalty Purchase Agreement by and among the registrant, Arena Pharmaceuticals, Inc. and 356 Royalty Inc., dated October 27, 2020 (Filed With SEC on February 19, 2021)

License Agreement by and between the registrant and Arena Pharmaceuticals, Inc., dated October 27, 2020 (Filed With SEC on February 19, 2021)

Form of Indemnification Agreement by and between the registrant and each director and executive officer (Filed With SEC on February 19, 2021)

Forms of grant notice, stock option agreement and notice of exercise under the Longboard Pharmaceuticals, Inc. 2020 Equity Incentive Plan (Filed With SEC on February 19, 2021)

Investors Rights Agreement by and among the registrant and certain of its stockholders, dated October 27, 2020 (Filed With SEC on February 19, 2021)

Longboard Pharmaceuticals, Inc. (23)